Erlonat 100mg
Available Dosages
| SKU | 1492 |
|---|---|
| Generic For | Taceva |
| Strength | 100mg |
| Manufacturer | Natco Pharma |
| Active Ingredient | Erlotinib |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 8.14 | US$ 244.20 | |||
|
|||||
Erlonat 100mg – Affordable Taceva Alternative for Lung Cancer
Erlonat 100 mg is formulated for the treatment of non-small cell lung cancer that has spread to surrounding tissues or other parts of the body. It is also useful in treating metastatic pancreatic cancer. The medicine has the active component Erlotinib, which is a member of a class of targeted anticancer drugs. It is an FDA-approved drug for the treatment of NSCLC after the failure of at least one prior chemotherapy regimen and is the first such drug to demonstrate an increase in survival in patients with advanced NSCLC.
What is Erlonat 100mg used for?
Erlonat is useful in:
- First line therapy of metastatic NSCLC
- Maintenance treatment of locally advanced and metastatic NSCLC when the disease has not progressed after four cycles of platinum based first line chemotherapy
- Locally advanced and metastatic NSCLC that has not responded to ≥ one previous chemotherapy regimen.
- First line therapy for locally advanced, surgically unresectable, or metastatic pancreatic cancer.
How does Erlonat work?
Erlonat works by inhibiting the enzyme tyrosine kinase, which is associated with human epidermal growth factor receptor (EGFR). It blocks the growth stimulation signals in cancer cells and decreases spread of lung or pancreatic cancer with increased survival.
What medications interact with Erlonat?
- Drugs such as clarithromycin, nefazodone, indinavir, atazanavir, voriconazole, ketoconazole, ritonavir, telithromycin, itraconazole, and saquinavir increase levels and the risk of toxicity. In this case, dose reduction is considered.
- Drugs such as rifabutin, phenytoin, phenobarbital, rifampin, rifapentine, and carbamazepine decreases levels and may decrease response. In this case, alternative therapy or increase dose should be considered.
- Concurrent use with ciprofloxacin may increase levels and risk of toxicity.
- Erlonat may decrease midazolam.
- Bleeding may occur if used along with warfarin.
- Avoid concurrent use of proton inhibitors and H2 blockers.
When should Erlonat not be used?
Erlonat is contraindicated in pregnant women and lactating women.
Use it with caution in the following conditions:
- Hepatic impairment
- Metastatic lung disease
- Pre-existing disease
- Pediatric patients
- Patients with child bearing potential
How should Erlonat be used?
- For adults, the recommended dose for the treatment of NSCLC is 150 mg daily. Take it one hour before or two hours after consuming food.
- 100 mg once daily is the recommended dose for the treatment of pancreatic cancer.
- Patients should be assessed for respiratory function periodically during the treatment. Discontinue Erlonat, if cough, dyspnea, or fever occurs.
- Patients are instructed to exercise caution while use highly effective contraceptive during and for at least two weeks after completion of treatment. Female patients are advised to inform their health care professional if pregnancy is planned or suspected.
- Patients are instructed to discontinue smoking during the treatment. Smoking decreases blood levels of Erlotinib.
- Patients are advised to wear sunscreen and protective clothing to decrease skin reaction.
- Patients are advised to notify health care specialist if severe, persistent, anorexia, diarrhea, vomiting, onset of worsening of skin rash, cough, unexplained dyspnea, and nausea may occur.
How long should Erlonat be used?
The duration of treatment with Erlonat varies, depending on your condition and your individual response to the treatment. Keep taking the medicine until your health care specialist tells you to stop.
Missed dose of Augmentin
Do not take an extra dose of Erlonat 100 mg. Wait until the next scheduled dose and take your normal dose then. Don’t try to make up for the missed dose by taking extra doses at a time. If you are not sure what to do, ask your health care professional.
How should Erlonat be stored?
- Keep your tablets in its original pack until it is time to take them out.
- Keep it in a cool, dry place, at controlled room temperature.
- Do not place it in the bathroom or near a sink. Keep it away from wet places.
- Keep the medicine where children and pets cannot reach.
What are the side effects of Erlonat?
- Respiratory system disorders- interstitial lung disease, cough, dyspnea
- Cardiovascular system disorders- myocardial infarction and ischemia
- Dermatological issues- dry skin, rash, bullous an exfoliative skin disorders, and pruritus
- Hematological issues- microangiopathic hemolytic anemia with thrombocytopenia
- Central nervous system disorders- fatigue, cerebrovascular accident
- EENT- corneal ulceration, conjunctivitis, corneal perforation
- Genitouetrine disorders- renal failure
- Gastrointestinal issues- diarrhea, anorexia, hepatotoxicity, stomatitis, increased liver enzymes, nausea, vomiting, gastrointestinal perforation, and abdominal pain
What is Erlotinib and what condition does it treat?
Erlotinib is a targeted cancer therapy medication belonging to the tyrosine kinase inhibitor class. Sold under brand names including Erlonat 100mg, this anticancer drug is primarily prescribed to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib works by blocking specific proteins that help cancer cells grow and multiply. Doctors typically prescribe this oral chemotherapy agent for patients whose tumours have certain genetic mutations, particularly EGFR (epidermal growth factor receptor) mutations. The medication represents an important treatment option for advanced or metastatic lung cancer when other therapies may not be suitable.
How does Erlotinib work in the body?
Erlotinib functions as an EGFR tyrosine kinase inhibitor, targeting cancer cells at the molecular level. The active ingredient in Erlonat 100mg blocks the epidermal growth factor receptor enzyme, which normally sends signals telling cells to grow and divide. By inhibiting this pathway, the anticancer medication prevents tumour cells from receiving growth signals, effectively slowing or stopping cancer progression. This targeted mechanism makes Erlotinib particularly effective against lung cancer and pancreatic cancer cells that have overactive EGFR pathways. Unlike traditional chemotherapy that affects all rapidly dividing cells, this precision medicine specifically targets cancerous cells.
How long does Erlonat 100mg take to work?
Erlonat 100mg containing Erlotinib begins working at the cellular level within hours of ingestion, but visible clinical improvements typically take longer to observe. Most patients undergoing lung cancer treatment notice symptom changes within 4 to 8 weeks of starting this tyrosine kinase inhibitor therapy. Oncologists usually assess treatment response through imaging scans after approximately two months of continuous use. The timeframe varies significantly between individuals depending on cancer type, stage, genetic factors, and overall health status. Some patients experience rapid tumour shrinkage while others show slower, steady disease stabilization with this targeted cancer medication.
When and how should I take Erlonat 100mg?
Take Erlonat 100mg on an empty stomach, at least one hour before eating or two hours after meals for optimal absorption. Most oncologists recommend taking this Erlotinib tablet once daily at the same time each day to maintain consistent blood levels of the cancer medication. Swallow the tablet whole with water without crushing or breaking it. Taking this tyrosine kinase inhibitor with food significantly reduces its effectiveness, so timing matters greatly. If you miss a dose and it's more than 12 hours until your next scheduled dose, take it immediately; otherwise, skip and continue your regular schedule.
Is Erlonat 100mg safe for long-term use?
Erlonat 100mg is designed for continuous long-term cancer treatment under ongoing medical supervision. Many patients with non-small cell lung cancer take this Erlotinib medication for months or even years as maintenance therapy to control disease progression. Clinical studies demonstrate that extended use of this tyrosine kinase inhibitor can be safe when properly monitored through regular blood tests, liver function checks, and imaging scans. Oncologists carefully balance the anticancer benefits against potential side effects, adjusting treatment plans as needed. Long-term safety depends on individual tolerance, cancer response, and monitoring for complications throughout the treatment journey.
Can I take Erlonat 100mg with other medicines?
Erlonat 100mg can interact with numerous medications, requiring careful coordination with your healthcare team. This Erlotinib-based cancer treatment may interact with proton pump inhibitors, antacids, blood thinners like warfarin, certain antibiotics, and antifungal medications. The tyrosine kinase inhibitor's effectiveness can be reduced by stomach acid reducers, while other drugs may increase side effect risks. Herbal supplements, particularly St John's Wort, can significantly affect how your body processes this anticancer medication. Always provide your oncologist and pharmacist with a complete list of all prescription drugs, over-the-counter medicines, and supplements before starting treatment.
How does Erlonat 100mg compare to similar medicines in its class?
Erlonat 100mg contains Erlotinib, which belongs to the first-generation EGFR tyrosine kinase inhibitor class alongside medications like gefitinib. Compared to these similar lung cancer treatments, Erlotinib demonstrates comparable effectiveness for patients with EGFR-mutated tumours. Newer generation inhibitors like osimertinib may offer advantages for specific resistance mutations but cost significantly more. Erlonat 100mg provides an established, well-researched option with extensive clinical data supporting its use. The medication's side effect profile is typical for this anticancer drug class, with skin rash and diarrhea being common. Choice between these targeted therapies depends on genetic testing results and individual cancer characteristics.
Is the generic Erlotinib as effective as branded versions?
Generic Erlotinib formulations like Erlonat 100mg contain the identical active pharmaceutical ingredient as branded versions and deliver equivalent therapeutic effects for lung cancer treatment. Regulatory agencies in the USA, UK, Australia, and Canada require generic cancer medications to demonstrate bioequivalence, meaning they work in your body the same way as original branded products. Erlonat provides the same tyrosine kinase inhibitor action at typically lower costs without compromising quality. Clinical outcomes, tumour response rates, and side effect profiles remain consistent across approved generic and branded Erlotinib versions. Many oncology centres now routinely prescribe generic anticancer medications for cost-effective treatment.
Where can I buy Erlonat 100mg online safely?
PremiumRxDrugs offers a safe, licensed platform to purchase Erlonat 100mg online with delivery to the USA, UK, Australia, Canada, and internationally. As an established pharmacy, we stock only authentic, manufacturer-sourced Erlotinib medications, ensuring you receive genuine cancer treatment rather than counterfeit products. The pharmacy provides competitive pricing on this tyrosine kinase inhibitor with discreet packaging and various shipping options, including free delivery on qualifying orders. With over a decade of serving patients requiring lung cancer medications, PremiumRxDrugs combines reliable prescription management, secure ordering, and authentic pharmaceutical sourcing for anticancer treatments you can trust.
Why do patients choose PremiumRxDrugs for Erlonat 100mg?
Patients select PremiumRxDrugs for Erlonat 100mg because of consistent access to affordable, genuine Erlotinib medication with reliable worldwide delivery. The licensed pharmacy's competitive pricing makes long-term lung cancer treatment more financially manageable compared to local pharmacy costs in many countries. Customers appreciate the straightforward reorder system and prescription management features that simplify ongoing anticancer therapy. Discreet packaging respects privacy while authentic manufacturer sourcing guarantees medication quality. Serving patients across the USA, UK, Australia, and Canada for more than ten years has built trust in delivering legitimate tyrosine kinase inhibitors without compromising safety or authenticity throughout extended cancer treatment journeys.
What are the common side effects of Erlotinib?
Erlotinib commonly causes skin-related reactions including acne-like rash, dry skin, and itching affecting up to 75% of patients taking this cancer medication. Diarrhea occurs frequently with this tyrosine kinase inhibitor, ranging from mild to moderate severity. Other typical side effects include fatigue, loss of appetite, nausea, and mouth sores. Some patients experience eye irritation or conjunctivitis during lung cancer treatment. Less common but notable effects include shortness of breath and cough. The characteristic skin rash, while bothersome, often indicates the medication is working effectively. Most side effects are manageable with supportive care and don't require stopping this anticancer therapy.
Who should avoid taking Erlotinib?
Erlotinib is contraindicated for pregnant women as this cancer medication can cause serious fetal harm and birth defects. Breastfeeding mothers should not use this tyrosine kinase inhibitor as it passes into breast milk. Patients with severe liver impairment require careful evaluation before starting this lung cancer treatment. Individuals with a history of severe lung disease or interstitial lung disease face increased risks with Erlotinib therapy. Those with known hypersensitivity to the active ingredient or formulation components should avoid this anticancer drug. Children have not been adequately studied for safety with this medication, making it unsuitable for paediatric use without specialist guidance.
Login
Sign Up
Login
Sign Up